Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors

Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors

Disclosed are compounds of Formula (IIa), wherein R1, R2, R3A, R3B, R3C, R3D, R3E, and R4 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Risi Roberto M, Hansen Todd M, Curtin Michael, Mastracchio Anthony, Penning Thomas, Gong Jianchun, Song Xiaohong, Dabbeeru Madhu Babu, Goswami Rajeev, Iguturi Omprakash Reddy, Tong Yunsong, Zhu Guidong, Tao Zhi-fu, Michaelides Michael, Miyashiro Juliem, Clark Richard F, Lai Chunqiu, Bruncko Milan, Ji Zhiqin, Souers Andrew, Frey Robin R, Woods Keith W, Florjancic Alan S
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disclosed are compounds of Formula (IIa), wherein R1, R2, R3A, R3B, R3C, R3D, R3E, and R4 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions comprising one or more compounds of Formula (IIa).